DE60238709D1 - 4-piperidinylalkylamin-derivate, antagonisten von muscarinrezeptoren - Google Patents
4-piperidinylalkylamin-derivate, antagonisten von muscarinrezeptorenInfo
- Publication number
- DE60238709D1 DE60238709D1 DE60238709T DE60238709T DE60238709D1 DE 60238709 D1 DE60238709 D1 DE 60238709D1 DE 60238709 T DE60238709 T DE 60238709T DE 60238709 T DE60238709 T DE 60238709T DE 60238709 D1 DE60238709 D1 DE 60238709D1
- Authority
- DE
- Germany
- Prior art keywords
- piperidinyl
- antagonists
- alkylamine derivatives
- muscarin
- receptors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33679501P | 2001-12-03 | 2001-12-03 | |
PCT/EP2002/013220 WO2003048124A1 (en) | 2001-12-03 | 2002-11-25 | 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60238709D1 true DE60238709D1 (de) | 2011-02-03 |
Family
ID=23317699
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60238709T Expired - Lifetime DE60238709D1 (de) | 2001-12-03 | 2002-11-25 | 4-piperidinylalkylamin-derivate, antagonisten von muscarinrezeptoren |
Country Status (15)
Country | Link |
---|---|
US (2) | US6627644B2 (de) |
EP (1) | EP1453805B1 (de) |
JP (1) | JP4353803B2 (de) |
KR (1) | KR100687992B1 (de) |
CN (1) | CN100352806C (de) |
AR (1) | AR037612A1 (de) |
AT (1) | ATE492535T1 (de) |
AU (1) | AU2002352125A1 (de) |
BR (1) | BR0214674A (de) |
CA (1) | CA2468691C (de) |
DE (1) | DE60238709D1 (de) |
MX (1) | MXPA04005076A (de) |
PL (1) | PL370765A1 (de) |
RU (1) | RU2300524C2 (de) |
WO (1) | WO2003048124A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2468691C (en) * | 2001-12-03 | 2011-03-08 | F. Hoffmann-La Roche Ag | 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists |
CA2492121A1 (en) | 2002-07-08 | 2004-01-15 | Ranbaxy Laboratories Limited | 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
TW200800953A (en) | 2002-10-30 | 2008-01-01 | Theravance Inc | Intermediates for preparing substituted 4-amino-1-(pyridylmethyl) piperidine |
US7488748B2 (en) * | 2003-01-28 | 2009-02-10 | Ranbaxy Laboratories Limited | 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
US7517905B2 (en) | 2003-04-09 | 2009-04-14 | Ranbaxy Laboratories Limited | Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
CA2522071A1 (en) | 2003-04-11 | 2004-10-21 | Ranbaxy Laboratories Limited | Azabicyclo derivatives as muscarinic receptor antagonists |
JP2007524641A (ja) | 2003-07-11 | 2007-08-30 | セラヴァンス, インコーポレーテッド | 置換4−アミノ−1−ベンジルピペリジン化合物 |
AU2005263578B2 (en) | 2004-07-16 | 2010-09-02 | Proteosys Ag | Muscarinic antagonists with PARP and SIR modulating activity as agents for inflammatory diseases |
EP1797040A1 (de) * | 2004-09-29 | 2007-06-20 | Ranbaxy Laboratories Limited | Muscarin-rezeptor-antagonisten |
EP1828174A1 (de) * | 2004-11-19 | 2007-09-05 | Ranbaxy Laboratories Limited | Azabicyclische antagonisten des muskarinrezeptors |
WO2006064304A1 (en) * | 2004-12-15 | 2006-06-22 | Ranbaxy Laboratories Limited | Acid addition salts of muscarinic receptor antagonists |
EP1888525A1 (de) * | 2005-05-03 | 2008-02-20 | Ranbaxy Laboratories Limited | 3,6-disubstituierte azabicyclo[3.1.0]hexanderivate als antagonisten des muskarinrezeptors |
TW200944526A (en) * | 2008-04-22 | 2009-11-01 | Vitae Pharmaceuticals Inc | Carbamate and urea inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
EP2387405A2 (de) | 2009-01-13 | 2011-11-23 | ProteoSys AG | Pirenzepin als mittel für die krebstherapie |
KR101034492B1 (ko) * | 2009-05-27 | 2011-05-17 | 하태헌 | 철도 차량의 발전 장치 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3718317A1 (de) | 1986-12-10 | 1988-06-16 | Bayer Ag | Substituierte basische 2-aminotetraline |
CA1331191C (en) | 1988-03-25 | 1994-08-02 | Bengt Ronny Andersson | Therapeutically useful tetralin derivatives |
FR2659323B1 (fr) | 1990-03-07 | 1992-06-12 | Synthelabo | Derives de 4-(aminomethyl) piperidine, leur preparation et leur application en therapeutique. |
FR2659853A1 (fr) | 1990-03-22 | 1991-09-27 | Midy Spa | Utilisation de derives 2-aminotetraliniques pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale. |
US6319920B1 (en) * | 1998-02-27 | 2001-11-20 | Syntex (U.S.A.) Llc | 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives |
RU2241702C2 (ru) | 2000-05-25 | 2004-12-10 | Ф.Хоффманн-Ля Рош Аг | Замещенные 1-аминоалкиллактамы, фармацевтическая композиция на их основе и способ их получения |
CZ20024199A3 (cs) | 2000-05-25 | 2004-01-14 | F. Hoffmann-La Roche Ag | Substituované 1-aminoalkyllaktamy a jejich použití jako antagonisty muskarinového receptoru |
CA2468691C (en) * | 2001-12-03 | 2011-03-08 | F. Hoffmann-La Roche Ag | 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists |
-
2002
- 2002-11-25 CA CA2468691A patent/CA2468691C/en not_active Expired - Fee Related
- 2002-11-25 WO PCT/EP2002/013220 patent/WO2003048124A1/en active Application Filing
- 2002-11-25 EP EP02787798A patent/EP1453805B1/de not_active Expired - Lifetime
- 2002-11-25 BR BR0214674-6A patent/BR0214674A/pt not_active IP Right Cessation
- 2002-11-25 AT AT02787798T patent/ATE492535T1/de not_active IP Right Cessation
- 2002-11-25 RU RU2004120556/04A patent/RU2300524C2/ru not_active IP Right Cessation
- 2002-11-25 CN CNB028240146A patent/CN100352806C/zh not_active Expired - Fee Related
- 2002-11-25 AU AU2002352125A patent/AU2002352125A1/en not_active Abandoned
- 2002-11-25 JP JP2003549316A patent/JP4353803B2/ja not_active Expired - Fee Related
- 2002-11-25 KR KR1020047008402A patent/KR100687992B1/ko not_active IP Right Cessation
- 2002-11-25 DE DE60238709T patent/DE60238709D1/de not_active Expired - Lifetime
- 2002-11-25 PL PL02370765A patent/PL370765A1/xx not_active Application Discontinuation
- 2002-11-25 MX MXPA04005076A patent/MXPA04005076A/es active IP Right Grant
- 2002-12-02 AR ARP020104639A patent/AR037612A1/es not_active Application Discontinuation
- 2002-12-02 US US10/308,081 patent/US6627644B2/en not_active Expired - Fee Related
-
2003
- 2003-07-01 US US10/611,193 patent/US6864266B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU2002352125A1 (en) | 2003-06-17 |
RU2004120556A (ru) | 2005-07-10 |
KR20050044633A (ko) | 2005-05-12 |
ATE492535T1 (de) | 2011-01-15 |
KR100687992B1 (ko) | 2007-02-27 |
CA2468691C (en) | 2011-03-08 |
EP1453805A1 (de) | 2004-09-08 |
JP4353803B2 (ja) | 2009-10-28 |
BR0214674A (pt) | 2004-10-19 |
RU2300524C2 (ru) | 2007-06-10 |
US20030162780A1 (en) | 2003-08-28 |
PL370765A1 (en) | 2005-05-30 |
CA2468691A1 (en) | 2003-06-12 |
CN100352806C (zh) | 2007-12-05 |
EP1453805B1 (de) | 2010-12-22 |
WO2003048124A1 (en) | 2003-06-12 |
US6627644B2 (en) | 2003-09-30 |
US6864266B2 (en) | 2005-03-08 |
MXPA04005076A (es) | 2004-08-19 |
AR037612A1 (es) | 2004-11-17 |
CN1599722A (zh) | 2005-03-23 |
JP2005517641A (ja) | 2005-06-16 |
US20040092554A1 (en) | 2004-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20035739D0 (no) | N-aroyl syklisk aminderivater som orexin reseptorantagonister | |
NO20040028L (no) | Substituerte anilinske piperidiner som MCH-selektive antagonister | |
NO20050429D0 (no) | Substituert kinolin-CCR5-reseptorantagonister | |
ATE525378T1 (de) | Himbacinanaloga als thrombinrezeptorantagonisten | |
ATE346043T1 (de) | Il-8-rezeptorantagonisten | |
GB0130347D0 (en) | Compounds | |
ATE328871T1 (de) | 4-phenyl-pyridin-derivate verwendbar als neurokinin-1 rezeptor antagonisten | |
NO20051871D0 (no) | Opioid reseptorantagonister | |
NO20041235L (no) | Kinolinderivater som neuropeptid Y antagonister | |
DE60238709D1 (de) | 4-piperidinylalkylamin-derivate, antagonisten von muscarinrezeptoren | |
DK1440059T3 (da) | 3-azabicyclo(3.1.0)hexanderivater som opioidreceptorantagonister | |
DK1305319T3 (da) | 4-phenyl-pyridinderivater som neurokinin-1-receptorantagonister | |
NO20025640L (no) | Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptorantagonister | |
DE60332816D1 (de) | Nk1-antagonisten | |
DE60224221D1 (de) | Aminotetralinderivate, antagonisten von muscarinrezeptoren | |
DE60222693D1 (de) | Nk1-antagonisten | |
ATE309994T1 (de) | Alkoxycarbonylaminobenzoesäure- oder alkoxycarbonylaminotetrazolylphenylderivate als ip-antagonisten | |
ATE394114T1 (de) | Somatostatin-antagonisten | |
ATE338043T1 (de) | 5-methoxy-8-aryl- 1,2,4ötriazolo 1,5-aöpyridine derivative als adenosin-rezeptor antagonisten | |
DE60210058D1 (de) | Alkoxycarbonylamino-heteroaryl-carbonsäurederivate als ip-antagonisten | |
ATE418542T1 (de) | Als ccr5-antagonisten verwendbare aryloxim- piperazine | |
DK1558259T3 (da) | Ureaderivater som IL-8 -receptorantagonister | |
NO20033223L (no) | Histamin-reseptor antagonister | |
DE60222015D1 (de) | Ccr-3-rezeptorantagonisten vii | |
DE60209885D1 (de) | Crf receptor antagonisten |